作者：
O'Donoghue,M.L. [1]
;
Bhatt,D.L. [2]
;
Flather,M.D. [3]
;
Goto,S. [4]
;
Angiolillo,D.J. [5]
;
Goodman,S.G. [6]
;
Zeymer,U. [7]
;
Aylward,P.E. [8]
;
Montalescot,G. [9]
;
Ziecina,R. [10]
;
Kobayashi,H. [11]
;
Ren,F. ;
Wiviott,S.D.
作者单位：
VA Boston Healthcare System, TIMI Study Group, Brigham and Women's Hospital, Boston, MA, United
[1]
University of Florida, College of Medicine, Jacksonville, FL, United States
[2]
Department of Clinical Pharmacology, Tokai University, School of Medicine, Kanagawa, Japan
[3]
Cardiovascular Division, TIMI Study Group, Brigham and Women's Hospital, 350 Longwood Avenue
[4]
Department of Medicine (Cardiology), Tokai University, School of Medicine, Kanagawa, Japan
[5]
Eisai Ltd., Frontier Product Creation Unit, European Knowledge Centre, Hatfield, United Kingdom
[6]
Institut de Cardiologie, Pitié-Salpêtrière University Hospital, Paris, France
[7]
Herzzentrum Ludwigshafen, Ludwigshafen, Germany
[8]
Department of Cardiovascular Medicine, Flinders Cardiovascular Centre, Adelaide, SA, Australia
[9]
Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada
[10]
Clinical Trials and Evaluation Unit, Royal Brompton Hospital, London, United Kingdom
[11]
发布时间
2013-11-20
换一批
